, Tracking Stock Market Picks
Enter Symbol:
Cytrx Corporation (CYTR) [hlAlert]

down 73.90 %

Cytrx Corporation (CYTR) rated Buy with price target $2 by Roth Capital

Posted on: Friday,  Jan 8, 2010  11:25 AM ET by Roth Capital

Roth Capital rated Buy Cytrx Corporation (NASDAQ: CYTR) on 01/08/2010, when the stock price was $8.89. Since
then, Cytrx Corporation has lost 73.90% as of 01/26/2016's recent price of $2.32.
If you would have followed this Roth Capital's recommendation on CYTR, you would have lost 73.9% of your investment in 2209 days.

CYTRX CORP. is engaged in the development and commercialization of pharmaceutical related products and services including human therapeutics focused on high-value critical- care therapies.

ROTH researches emerging growth equities in the media, technology, telecommunications, healthcare, consumer, energy and industrial sectors. The research is focused on companies with market capitalization of between $100 million - $1 billion. Our coverage universe includes approximately 180 small cap growth companies around the globe including several companies from China. With an average market cap of approximately $500 million, our objective is to identify rapidly growing companies with significant long term growth prospects.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
1/8/2010 11:25 AM Buy
8.89 14.00
as of 12/31/2010
1 Week down  -16.83 %
1 Month down  -19.23 %
3 Months up  12.00 %
1 YTD down  -33.85 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy